Emily Pimblett - Jan 13, 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
SVP, Finance and CAO
Signature
/s/ Emily Pimblett
Stock symbol
CLYM
Transactions as of
Jan 13, 2025
Transactions value $
$0
Form type
4
Date filed
1/15/2025, 04:15 PM
Previous filing
Dec 20, 2024
Next filing
Mar 20, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jan 13, 2025 Common Stock 100K $1.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 13, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 13, 2029, subject to the Reporting Person's continued service.